Not exactly, he said announcement of extension BEFORE announcing pivotal would be disastrous, which is hogwash. The order is irrelevant. What matters is that Anavex moves into the pivotal trial, for which preparations are already underway according to the company.
an extension w/o moving forward to the next trial would be bad.
Why would it be "bad" to agree to an extension before they announce the next trial? Why do you assume they'll be ready for the next trial within the next couple of weeks?
News 
Market Data 
Discover 
AI
